Isoptin (Verapamil Hydrochloride)

Verapamil hydrochloride blocks L‑type calcium channels in cardiac and vascular smooth muscle. By reducing calcium entry, it decreases myocardial contractility, slows atrioventricular nodal conduction, and lowers peripheral vascular resistance, which together lower blood pressure and stabilize heart rhythm.

The specific dose of Isoptin is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosing regimens are individualized and should follow the prescriber’s instructions and local clinical guidelines.

Safety data for verapamil hydrochloride in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To order Isoptin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and required import documentation.

Isoptin (verapamil) is a non‑dihydropyridine calcium channel blocker, distinguished by its pronounced effects on cardiac conduction and contractility, making it useful for arrhythmia control. Dihydropyridine agents such as amlodipine primarily cause vasodilation with less impact on heart rate.

Store Isoptin at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly sealed to maintain sterility.

Isoptin is supplied as an intravenous solution and is administered directly into a vein by a qualified healthcare professional. The infusion rate and duration are set by the prescriber according to the clinical situation and patient response.

Serious risks include severe hypotension, marked bradycardia, atrioventricular block, and rare allergic reactions such as anaphylaxis. Patients should be monitored continuously for cardiovascular changes during and after infusion.

Isoptin is contraindicated in patients with known hypersensitivity to verapamil, severe hypotension, advanced heart block without a pacemaker, and those with uncompensated heart failure. Clinicians should assess each patient’s medical history before initiating therapy.